Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Laura HedgesBrian G Lake

Abstract

The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes. DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11. DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes. Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver. Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.

References

Jan 29, 2002·Toxicology·David M SoderlundMyra L Weiner
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jeffrey C StevensMatthew J Zaya
Feb 27, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N J ProctorA Rostami-Hodjegan
Dec 20, 2005·Archives of Biochemistry and Biophysics·Kosuke NishiBruce D Hammock
Jan 3, 2006·Biochemical Pharmacology·Matthew K RossPhilip M Potter
Jul 14, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Teruko ImaiKan Chiba
Jul 21, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephen J GodinMatthew K Ross
Apr 20, 2007·Toxicology and Applied Pharmacology·J Allen CrowMatthew K Ross
Jun 20, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephen J GodinMatthew K Ross
Oct 16, 2007·Journal of Biochemical and Molecular Toxicology·Matthew K Ross, J Allen Crow
Apr 15, 2008·Pharmacology & Therapeutics·Ronald N Hines
Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Oct 25, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Edward J ScollonMichael F Hughes
Nov 11, 2008·Current Drug Metabolism·J Brian Houston, Aleksandra Galetin
Feb 10, 2009·Expert Opinion on Drug Metabolism & Toxicology·Masoud JameiAmin Rostami-Hodjegan
Jun 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hao-Jie ZhuJohn S Markowitz
Mar 5, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Stephen J GodinRogelio Tornero-Velez
Dec 8, 2010·Journal of Agricultural and Food Chemistry·Hideo Kaneko
May 5, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jie WangChristopher J Patten
Jun 29, 2011·Archives of Toxicology·David M Soderlund
Sep 29, 2011·Topics in Current Chemistry·Kazuki MikataHideo Kaneko
Oct 22, 2011·Topics in Current Chemistry·Ryozo TsujiSatoshi Kawamura
Apr 17, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuichiro SatoTakashi Usui
Jun 7, 2012·Critical Reviews in Toxicology·Miyoung YoonHarvey J Clewell
Aug 4, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rogelio Tornero-VelezMichael F Hughes
Jun 1, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Brahim AchourAmin Rostami-Hodjegan
Aug 26, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Barbara A WetmoreRussell S Thomas
Jan 31, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ronald N HinesD Gail McCarver
Feb 24, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gina SongMiyoung Yoon
Mar 15, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Laura HedgesBrian G Lake

❮ Previous
Next ❯

Citations

Oct 9, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Pankajini MallickMiyoung Yoon
May 19, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Pankajini MallickMarjory Moreau
Jul 17, 2020·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Laura HedgesBrian G Lake
Nov 5, 2020·Medicina·Iga Hołyńska-Iwan, Karolina Szewczyk-Golec
Apr 9, 2021·European Journal of Medicinal Chemistry·Galina F MakhaevaRudy J Richardson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.